시장보고서
상품코드
2109651

생체활성 유리 시장(2026-2030년)

Global Bioactive Glass Market 2026-2030

발행일: | 리서치사: 구분자 TechNavio | 페이지 정보: 영문 291 Pages | 배송안내 : 즉시배송

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 등을 복사 및 붙여넣기 할 수 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 2,500 금액 안내 화살표 ₩ 3,579,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,000 금액 안내 화살표 ₩ 5,726,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 생체활성 유리 시장은 2025년부터 2030년까지 20억 8,500만 달러 증가하고, 예측 기간 동안 CAGR은 20.8%에 달할 것으로 예측됩니다.

전 세계 생체활성 유리 시장에 관한 본 보고서는 종합적인 분석, 시장 규모 및 전망, 동향, 성장 요인, 과제는 물론 약 25개 업체를 대상으로 한 벤더 분석을 제공합니다.

본 보고서는 현재의 시장 상황, 최신 시장 동향 및 촉진요인, 그리고 전반적인 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 고령 인구 증가에 따른 골 이식 대체재에 대한 전 세계적 수요 확대, 치과 치료에서 재석회화에 대한 임상적 선호도 증가로 인한 특수 재료 및 소모품 수요 확대, 그리고 나노기술 통합을 통한 조직 공학용 스캐폴드의 생물학적 성능 향상 등의 요인에 의해 주도되고 있습니다.

본 조사는 업계 주요 관계자로부터 얻은 정보를 포함한 1차 정보와 2차 정보를 객관적으로 결합하여 수행되었습니다. 본 보고서에는 주요 기업에 대한 분석 외에도 종합적인 시장 규모 데이터, 지역별 분석을 포함한 부문별 데이터, 그리고 공급업체 현황이 수록되어 있습니다. 또한, 시장 규모 실적 및 예측 데이터도 포함되어 있습니다.

시장 범위
기준 연도 2025년
종료 연도 2030년
조사 기간 2026-2030년
성장 모멘텀 가속
2026년 전년 대비 19.6%
CAGR 20.8%
증가액 20억 8,500만 달러

본 조사에서는 메조포러스 생체활성 유리 매트릭스의 광범위한 채택이 표적화된 국소적 약물전달을 최적화할 것이며, 이것이 향후 수년간 전 세계 생체활성 유리 시장의 성장을 견인할 주요 요인 중 하나라고 규명하고 있습니다. 또한, 적층 제조 기술의 활용 확대에 따라 환자별로 맞춤화된 정형외과용 스캐폴드가 가능해지며, 항균 이온을 풍부하게 함유한 코팅의 급속한 보급이 의료기기의 골유착 성능을 향상시킴에 따라 시장에서 상당한 수요가 발생할 것으로 전망됩니다.

목차

제1장 주요 요약

제2장 Technavio 분석

제3장 시장 구도

제4장 시장 규모

제5장 시장 규모 실적

제6장 정성 분석

제7장 Five Forces 분석

제8장 시장 세분화 : 제품별

제9장 시장 세분화 : 용도별

제10장 시장 세분화 : 폼팩터별

제11장 고객 상황

제12장 지역별 상황

제13장 촉진요인, 과제, 기회

제14장 경쟁 구도

제15장 경쟁 분석

제16장 부록

KSM

The global bioactive glass market is forecasted to grow by USD 2085.0 mn during 2025-2030, accelerating at a CAGR of 20.8% during the forecast period. The report on the global bioactive glass market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population base accelerates global demand bone graft substitutes, rising clinical preference dental care remineralization boosts specialized material consumables, technological advancements nanotechnology integration enhance biological performance tissue engineering scaffolds.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 202619.6%
CAGR20.8%
Incremental Value$2085.0 mn

Technavio's global bioactive glass market is segmented as below:

By Product

  • Silicate-based glass
  • Phosphate-based glass
  • Borate-based glass

By Application

  • Medical
  • Dentistry
  • Cosmetics
  • Others

By Form Factor

  • Powders and nano-powders
  • Granules

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the extensive incorporation mesoporous bioactive glass matrices optimizes targeted localized drug delivery as one of the prime reasons driving the global bioactive glass market growth during the next few years. Also, growing utilization additive manufacturing architectures enables personalized patient specific orthopedic scaffolds and rapid penetration antimicrobial ion enriched coatings enhances medical device osseointegration performance will lead to sizable demand in the market.

The report on the global bioactive glass market covers the following areas:

  • Global bioactive glass market sizing
  • Global bioactive glass market forecast
  • Global bioactive glass market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global bioactive glass market vendors that include Arthrex Inc., Baxter International Inc., Berkeley Advanced Biomaterials, Biocomposites Ltd., BioMin Technologies Ltd., BISCO Inc., Bonalive Biomaterials Ltd., BoneSupport Holding AB, CAM Bioceramics BV, Ed. Geistlich Sohne AG, GC Corp., GNI Group Ltd., Medtronic Plc, Mo Sci Corp., NORAKER, NovaBone Products LLC, SCHOTT AG, Stryker Corp., Synthera Lifesciences Pvt. Ltd., Zimmer Biomet Holdings Inc.. Also, the global bioactive glass market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Market Segmentation by Form Factor
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Bioactive Glass Market 2020 - 2024
    • Historic Market Size - Data Table on Global Bioactive Glass Market 2020 - 2024 ($ million)
  • 5.2 Product segment analysis 2020 - 2024
    • Historic Market Size - Product Segment 2020 - 2024 ($ million)
  • 5.3 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.4 Form Factor segment analysis 2020 - 2024
    • Historic Market Size - Form Factor Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on global bioactive glass market
  • 6.2 Impact of geopolitical conflicts on global bioactive glass market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Product

  • 8.1 Market segments
  • 8.2 Comparison by Product
  • 8.3 Silicate-based glass - Market size and forecast 2025-2030
  • 8.4 Phosphate-based glass - Market size and forecast 2025-2030
  • 8.5 Borate-based glass - Market size and forecast 2025-2030
  • 8.6 Market opportunity by Product
    • Market opportunity by Product ($ million)

9 Market Segmentation by Application

  • 9.1 Market segments
  • 9.2 Comparison by Application
  • 9.3 Medical - Market size and forecast 2025-2030
  • 9.4 Dentistry - Market size and forecast 2025-2030
  • 9.5 Cosmetics - Market size and forecast 2025-2030
  • 9.6 Others - Market size and forecast 2025-2030
  • 9.7 Market opportunity by Application
    • Market opportunity by Application ($ million)

10 Market Segmentation by Form Factor

  • 10.1 Market segments
  • 10.2 Comparison by Form Factor
  • 10.3 Powders and nano-powders - Market size and forecast 2025-2030
  • 10.4 Granules - Market size and forecast 2025-2030
  • 10.5 Market opportunity by Form Factor
    • Market opportunity by Form Factor ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 Spain - Market size and forecast 2025-2030
    • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 Japan - Market size and forecast 2025-2030
    • 12.5.3 India - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Indonesia - Market size and forecast 2025-2030
    • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 UAE - Market size and forecast 2025-2030
    • 12.6.4 Turkey - Market size and forecast 2025-2030
    • 12.6.5 Argentina - Market size and forecast 2025-2030
    • 12.6.6 Colombia - Market size and forecast 2025-2030
    • 12.6.7 South Africa - Market size and forecast 2025-2030
    • 12.6.8 Israel - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Increasing geriatric population base accelerates global demand bone graft substitutes
    • Rising clinical preference dental care remineralization boosts specialized material consumables
    • Technological advancements nanotechnology integration enhance biological performance tissue engineering scaffolds
  • 13.2 Market challenges
    • High manufacturing expenditure limits general commercial viability across emerging healthcare markets
    • Prolonged regulatory evaluation pathways delay rapid introduction innovative bioactive material formulations
    • Inadequate structural mechanical strength restricts broader clinical deployment load bearing applications
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Extensive incorporation mesoporous bioactive glass matrices optimizes targeted localized drug delivery
    • Growing utilization additive manufacturing architectures enables personalized patient specific orthopedic scaffolds
    • Rapid penetration antimicrobial ion enriched coatings enhances medical device osseointegration performance

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Arthrex Inc.
    • Arthrex Inc. - Overview
    • Arthrex Inc. - Product / Service
    • Arthrex Inc. - Key offerings
    • SWOT
  • 15.5 Baxter International Inc.
    • Baxter International Inc. - Overview
    • Baxter International Inc. - Business segments
    • Baxter International Inc. - Key offerings
    • Baxter International Inc. - Segment focus
    • SWOT
  • 15.6 Berkeley Advanced Biomaterials
    • Berkeley Advanced Biomaterials - Overview
    • Berkeley Advanced Biomaterials - Product / Service
    • Berkeley Advanced Biomaterials - Key offerings
    • SWOT
  • 15.7 Biocomposites Ltd.
    • Biocomposites Ltd. - Overview
    • Biocomposites Ltd. - Product / Service
    • Biocomposites Ltd. - Key offerings
    • SWOT
  • 15.8 BioMin Technologies Ltd.
    • BioMin Technologies Ltd. - Overview
    • BioMin Technologies Ltd. - Product / Service
    • BioMin Technologies Ltd. - Key offerings
    • SWOT
  • 15.9 BISCO Inc.
    • BISCO Inc. - Overview
    • BISCO Inc. - Product / Service
    • BISCO Inc. - Key offerings
    • SWOT
  • 15.10 Bonalive Biomaterials Ltd.
    • Bonalive Biomaterials Ltd. - Overview
    • Bonalive Biomaterials Ltd. - Product / Service
    • Bonalive Biomaterials Ltd. - Key offerings
    • SWOT
  • 15.11 Ed. Geistlich Sohne AG
    • Ed. Geistlich Sohne AG - Overview
    • Ed. Geistlich Sohne AG - Product / Service
    • Ed. Geistlich Sohne AG - Key offerings
    • SWOT
  • 15.12 GC Corp.
    • GC Corp. - Overview
    • GC Corp. - Product / Service
    • GC Corp. - Key offerings
    • SWOT
  • 15.13 GNI Group Ltd.
    • GNI Group Ltd. - Overview
    • GNI Group Ltd. - Product / Service
    • GNI Group Ltd. - Key offerings
    • SWOT
  • 15.14 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT
  • 15.15 SCHOTT AG
    • SCHOTT AG - Overview
    • SCHOTT AG - Product / Service
    • SCHOTT AG - Key offerings
    • SWOT
  • 15.16 Stryker Corp.
    • Stryker Corp. - Overview
    • Stryker Corp. - Business segments
    • Stryker Corp. - Key offerings
    • Stryker Corp. - Segment focus
    • SWOT
  • 15.17 Synthera Lifesciences Pvt. Ltd.
    • Synthera Lifesciences Pvt. Ltd. - Overview
    • Synthera Lifesciences Pvt. Ltd. - Product / Service
    • Synthera Lifesciences Pvt. Ltd. - Key offerings
    • SWOT
  • 15.18 Zimmer Biomet Holdings Inc.
    • Zimmer Biomet Holdings Inc. - Overview
    • Zimmer Biomet Holdings Inc. - Business segments
    • Zimmer Biomet Holdings Inc. - Key news
    • Zimmer Biomet Holdings Inc. - Key offerings
    • Zimmer Biomet Holdings Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기